(Q46203992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Chemoprevention: drug pricing and mortality: the case of tamoxifen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Joy Melnikow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christina Kuenneth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

L Jay Helms

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Amber Barnato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Miriam Kuppermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

James Nuovo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

950-958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16865680%20AND%20SRC:MED&resulttype=core&format=json

Chemoprevention of breast cancer: recommendations and rationale

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

Tamoxifen for breast cancer prevention: a framework for clinical decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22075

1 reference

7 January 2021

Dramatic improvement or death spiral--two members of congress assess the Medicare bill

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

The epidemiology of senile cataracts: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Estimating hip fracture morbidity, mortality and costs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Excess mortality or institutionalization after hip fracture: men are at greater risk than women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Hip fractures in Finland and Great Britain--a comparison of patient characteristics and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

11-year results in 2,846 patients of the Peterborough Hip Fracture Project: reduced morbidity, mortality and hospital stay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

The clinical course of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980-1995

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Canada's Population Health Model (POHEM): a tool for performing economic evaluations of cancer control interventions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22075

7 January 2021